Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Nefazodone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nefazodone 100mg tablets
0403040T0AAAAAA
|
Nefazodone hydrochloride | Nefazodone hydrochloride | Central Nervous System | 9 |
|
Dutonin 100mg tablets
0403040T0BBAAAA
|
Dutonin | Nefazodone hydrochloride | Central Nervous System | No data available |
|
Dutonin 200mg tablets
0403040T0BBABAB
|
Dutonin | Nefazodone hydrochloride | Central Nervous System | No data available |
|
Dutonin tablets treatment initiation pack
0403040T0BBACAC
|
Dutonin | Nefazodone hydrochloride | Central Nervous System | No data available |
|
Generic Dutonin tablets treatment initiation pack
0403040T0AAACAC
|
Nefazodone hydrochloride | Nefazodone hydrochloride | Central Nervous System | No data available |
|
Nefazodone 200mg tablets
0403040T0AAABAB
|
Nefazodone hydrochloride | Nefazodone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.